JUA clinical guidelines for benign prostatic hyperplasia-Reference-Cited by-同舟云学术

JUA clinical guidelines for benign prostatic hyperplasia

Published:2011-11 Issue:11 Volume:18 Page:e1-e33
ISSN:0919-8172
Container-title:International Journal of Urology
language:en
Short-container-title:

Author:

Homma Yukio,Gotoh Momokazu,Yokoyama Osamu,Masumori Naoya,Kawauchi Akihiro,Yamanishi Tomonori,Ishizuka Osamu,Seki Narihito,Kamoto Toshiyuki,Nagai Atsushi,Ozono Seiichiro

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2011.02861.x/fullpdf

Reference356 articles.

1. Clinical guidelines for overactive bladder;Yamaguchi;Int. J. Urol.,2009

2. Clinical guideline for male lower urinary tract symptoms;Homma;Int. J. Urol.,2009

3. Japanese guideline for diagnosis and treatment of interstitial cystitis;Homma;Int. J. Urol.,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-effectiveness analysis of minimally invasive surgical treatments for benign prostatic hyperplasia: implications for Japan’s public healthcare system;Journal of Medical Economics;2024-04-08

2. Phytotherapy Adds to the Therapeutic Armamentarium for the Treatment of Mild-To-Moderate Lower Urinary Tract Symptoms in Men;Urologia Internationalis;2019-12-18

3. A critical review of recent clinical practice guidelines on the diagnosis and treatment of non-neurogenic male lower urinary tract symptoms;Canadian Urological Association Journal;2015-07-17

4. Effects of preoperative dutasteride treatment in holmium laser enucleation of the prostate;International Journal of Urology;2015-01-29

5. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results;BJU International;2014-01-09